PROQOLID™, the database of choice for information on Clinical Outcome Assessments (COAs) which was launched in 2002. For more information about PROQOLIDTM and how to subscribe to the database, click here.
PROLABELS™, our unique database that gathers information on drugs approved with COA-labeling claims granted by the FDA and the EMA, was launched in 2006. To learn more about PROLabelsTM and how to subscribe to the database, click here.
PROINSIGHT™, the database that centralizes and summarizes published regulatory recommendations concerning the use of COAs to determine treatment benefit and to inform on drug approval and health technology assessment (HTA) review. To learn more about PROINSIGHTTM and how to subscribe to the database, click here.